Jul 19 |
Eli Lilly stock soars after Zepbound gets approval in China
|
Jul 19 |
Stock Market Rotation Gets Rough; ASML, Eli Lilly, CrowdStrike, UnitedHealth In Focus: Weekly Review
|
Jul 19 |
Eli Lilly and Company (LLY) is Attracting Investor Attention: Here is What You Should Know
|
Jul 19 |
Lilly alone in bidding for Morphic; Novartis won’t yet file MorphoSys drug
|
Jul 19 |
Eli Lilly's Famed Weight Loss Drug Zepbound Scores Chinese Approval
|
Jul 19 |
Eli Lilly weight loss drug approved in China
|
Jul 19 |
Rivals Emerge to Ozempic and Zepbound—but With a Lag
|
Jul 19 |
Nvidia Recently Completed a 10-for-1 Stock Split: Here Are the 3 Likeliest Candidates to Become Wall Street's Next Stock-Split Stocks
|
Jul 19 |
Palantir, Netflix, Domino's Pizza, Eli Lilly, Tesla: Why These 5 Stocks Are On Investors' Radars Today
|
Jul 18 |
Dow Jones Futures: Netflix Subscribers Jump As Tesla, Nvidia Resilient; President Biden Near Exiting Race?
|